NRG raises Series A funds for Parkinson’s and ALS therapy development

Pharmaceutical Technology

Read more

Funding for NRG Therapeutics to work on mitochondria link to Parkinson’s and...Parkinson’s disease drug hunters think outside the α-synuclein box